PDL BIOPHARMA, INC. 4
4 · PDL BIOPHARMA, INC. · Filed Oct 3, 2007
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Sale
Common Stock
2007-10-02$22.58/sh−645$14,564→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2007-10-02−645→ 21,970 totalExercise: $17.13Exp: 2013-07-20→ Common Stock (645 underlying) - Exercise/Conversion
Common Stock
2007-10-02$17.13/sh+645$11,049→ 645 total
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Option vests with respect to approximately 645 shares per month and 11 shares remained exercisable immediately after this transaction. Only vested options are exercisable